Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 5/20 | 0.42 |
| ▸ | CA4 | P22748 | 5/20 | 0.42 |
| ▸ | CA6 | P23280 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24829920 | 0.98 | NOS1 (0.45) | KMT2ANOS1NOS2CA1CA2 | |
| SCHEMBL18224272 | 0.98 | NOS1 (0.45) | KMT2ANOS1NOS2CA1CA2 | |
| SCHEMBL23781877 | 0.80 | NPC1 (0.38) | KMT2ACA1CA2CA4CA6 | |
| SCHEMBL23781934 | 0.80 | NPC1 (0.38) | KMT2ACA1CA2CA4CA6 | |
| SCHEMBL10751088 | 0.79 | CA1 (0.42) | KMT2ACA1CA2CA4CA6 | |
| SCHEMBL23781905 | 0.78 | CA1 (0.38) | KMT2ACA1CA2CA4CA6 | |
| SCHEMBL23781906 | 0.78 | CA1 (0.38) | KMT2ACA1CA2CA4CA6 | |
| SCHEMBL5064686 | 0.77 | NOS1 (0.44) | KMT2ANOS1NOS2CA1CA2 | |
| SCHEMBL7157465 | 0.77 | NOS1 (0.44) | KMT2ANOS1NOS2CA1CA2 | |
| SCHEMBL10502755 | 0.77 | NOS1 (0.44) | KMT2ANOS1NOS2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685705-B2 | Method for producing α-allylated cycloalkanone | KAO CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| US-11685705-B2 | Method for producing α-allylated cycloalkanone | KAO CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| US-20220153672-A1 | METHOD FOR PRODUCING ALPHA-ALLYLATED CYCLOALKANONE | KAO CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
| US-20220153671-A1 | METHOD FOR PRODUCING ALPHA-ALLYLATED CYCLOALKANONE | KAO CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153671-A1 | METHOD FOR PRODUCING ALPHA-ALLYLATED CYCLOALKANONE | ADH1A, ADH1C, ADH5 | KMT2A 4586/4885NOS1 1055/4885NOS2 1380/4885 |
| US-20220153672-A1 | METHOD FOR PRODUCING ALPHA-ALLYLATED CYCLOALKANONE | AKR1C3, PYM1, AKR1A1 | KMT2A 4031/4885NOS1 402/4885NOS2 595/4885 |
| US-11685705-B2 | Method for producing α-allylated cycloalkanone | AKR1C3, GALK1, PYM1 | KMT2A 4012/4885NOS1 370/4885NOS2 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.